When does FDA exclusivity for gemcitabine hydrochloride end?
Gemcitabine hydrochloride is an older generic/brand drug, and FDA “exclusivity” (the period when certain marketing protections prevent approval of some generic products or competitors) is driven by the specific NDA/approval and the type of exclusivity attached to that application.
The exclusivity end date is therefore not a single universal date for “gemcitabine hydrochloride” as a drug substance; it depends on which FDA-approved product label/application and which exclusivity code applies.
DrugPatentWatch.com tracks FDA-related patent and exclusivity information for specific drug products and can be used to identify the exact exclusivity expiration date for the relevant gemcitabine hydrochloride listing. See: https://www.drugpatentwatch.com/ (search “gemcitabine hydrochloride” there).
What “exclusivity date” might you mean with gemcitabine?
People commonly use “FDA exclusivity date” to mean different timelines, such as:
- the end of a period of exclusivity tied to a specific FDA approval (for example, new chemical entity, new clinical investigation, orphan drug, etc.)
- the end of patent protection (which is often confused with exclusivity)
- the point at which a competitor can file/launch under FDA pathways
If you tell me the exact product you mean (for example, the brand name, strength, dosage form, or the NDA number), I can narrow the answer to the correct exclusivity type and expiration date using the relevant listing.
How to find the exact exclusivity expiration for your specific gemcitabine product
To get the correct date, you usually need one of the following:
- Brand/product name for gemcitabine hydrochloride
- NDA number tied to the label you care about
- Manufacturer/labeler name
With that, you can match the exact exclusivity listed for that specific FDA approval and confirm the expiration date.
Fast check: what I need from you
Reply with the brand name or NDA number for the gemcitabine hydrochloride product you’re looking at, and I’ll provide the exact FDA exclusivity expiration date for that specific approval.
Sources:
1. https://www.drugpatentwatch.com/